Grants for innovative startups: JEI, CIR, CII, EIC Accelerator (EU 2026)

Young Innovative Enterprise status targets SMEs in the EU sense (fewer than 250 employees, turnover under €50 million or balance sheet under €43 million) created less than eight years ago and where at least 15% of deductible charges correspond to research and development expenses in the CIR sense. The R&D condition is assessed for the current fiscal year and must be attested annually in the tax return (specific form).

The main exemption concerns employer charges on compensation paid to R&D personnel (researchers, R&D engineers, R&D technicians, R&D project managers, industrial property lawyers, pre-competitive testing personnel). The exemption covers sickness, maternity, disability, basic retirement, family allowances — approximately 30 to 35% of usual employer charges. It applies to the compensation portion below 4.5 SMIC (annual ceiling) and is limited to 200% of PMSS (monthly Social Security ceiling) per establishment.

On direct taxation, JEI benefits from income tax exemption (IR or IS) for the first year then a 50% rebate for the second year. Beyond, the common-law regime applies. JEI benefit also includes Cotisation Foncière des Entreprises (CFE) exemption for 7 years on municipal decision (article 1466 D CGI). A property tax (TFPB) exemption over 7 years is also possible on R&D premises.

The Research Tax Credit (article 244 quater B CGI) constitutes the most powerful fiscal scheme for R&D projects. The rate is 30% of eligible expenses within €100 million per year, then 5% beyond. For an SME in the EU sense, a 50% complement on R&D operating expenses applies automatically (flat-rate calculated on R&D salaries × 1.5). Eligible expenses cover R&D personnel salaries, R&D fixed asset depreciation, intellectual property fees, certified R&D subcontracting, technological watch costs (limited to €60,000 per year).

CIR is restitutable for SMEs in the EU sense and for JEIs: if the credit exceeds tax due, the balance is refunded the following year (or immediately for JEIs after filing). This accelerated restitution is one of the keys to financing French deeptech launch. Average restitution time is 6 to 12 months after declaration filing. An SME in JEI thus stacks the R&D employer charge exemption (up to 35% of charged salary) AND the CIR (30% of R&D expenses on the expanded base).

The Innovation Tax Credit (CII), instituted by the 2013 Finance Law and renewed, specifically targets SMEs (fewer than 250 employees, turnover < €50M). It refunds 20% of expenses for prototype design or pilot installations of a new product, within an annual cap of €400,000 of expenses (i.e. €80,000 maximum credit). Unlike CIR, CII does not require a fundamental R&D project but applies to incremental product innovation.

The CIR + CII + JEI + French Tech Émergence articulation can generate public co-financing equivalent to 50 to 70% of total R&D expenses during the first years. The main administrative risk is CIR audit: approximately 8 to 12% of CIR files are subject to in-depth audit by the public finance directorate. Rigorous documentation (lab notebook, R&D time-sheets, subcontracting contracts, certification attestations) is critical.

• JEI — R&D employer charges exemption 8 years + IS first year + tapering
• CIR — 30% of R&D expenses (up to €100M base), restitutable for SMEs
• CII — 20% of product innovation expenses (cap €400k)
• French Tech Émergence — up to €90,000 for feasibility
• i-Lab contest — up to €600,000 for POC
• BPI Innovation guarantee — covers 70-80% of R&D bank loan

The European Innovation Council (EIC) operates three distinct instruments within Horizon Europe. EIC Pathfinder funds upstream research (TRL 1 to 3): €3-4 million projects over 3 years for international consortia. EIC Transition funds the lab-to-market transition (TRL 4 to 6): up to €2.5 million in subsidy for deeptechs consolidating a POC. EIC Accelerator funds industrialization and market launch (TRL 6 to 9): up to €2.5 million in subsidy combined with €15 million in equity, for deeptech SMEs with European ambition.

Horizon Europe thematic programmes cover six major clusters: health, culture/creativity, civil security, digital/industry/space, climate/energy/mobility, food/bioeconomy. Each cluster launches several calls for proposals per year, with typical projects of €3 to €7 million over 36 to 48 months. SMEs can participate as coordinator (with a consortium of 3 to 8 partners) or as partner of a larger consortium.

Horizon Europe funding rate is 70% for for-profit organizations and 100% for universities, research institutes, and non-profit organizations. Funding covers salaries (calculated at actual cost), depreciation, subcontracting, travel and meeting costs. Average time between submission and grant agreement signature is 8 to 10 months; disbursement then occurs every 6 months based on progress reports.

The Enterprise Europe Network (EEN), operated by CCIs and Eurochambres, freely supports SMEs in preparing Horizon Europe files and finding consortium partners. The network has 600 locations in 60 countries and represents one of the most-used access levers for French SMEs wishing to enter EU funding. Nationally, the Horizon Europe National Contact Point (NCP) offers training, file reviews, and connections.

The optimal sequence for a deeptech project begins with JEI status from creation (validation by tax rescript recommended), then CIR at the first fiscal year closing. The French Tech Émergence grant (€90,000) can be solicited in the first 12 months to fund a feasibility study or POC. The i-Lab contest (€600,000) intervenes after POC validation, generally at 18-24 months. At this stage, the project must present market proof (letters of intent, pilot contracts, product demonstration).

Scale-up to European level (EIC Transition or EIC Accelerator) typically occurs at 24-36 months, when the project has a functional product and consolidated team. An EIC Accelerator file preparation time is 4 to 6 months (with EEN or specialized consultant support), and European Commission instruction time adds 4 to 6 months. Anticipated preparation is therefore necessary to align the financing calendar with the company's cash needs.

Several pitfalls specific to innovation schemes deserve vigilance. First: qualification of R&D expenses in the CIR sense (article 49 septies F annex III CGI) is narrow — product development, marketing, or commercialization expenses are not eligible. Second: CIR audit prescription period is three years after declaration filing, requiring retention of all technical documentation during this period. Third: stacking JEI + CIR + French Tech is authorized but the base cannot be counted twice — a JEI-exempted salary expense cannot be included in the CIR base at full rate.

At EU level, other schemes complement the French offering. Innovate UK (up to €5M per project in collaborative R&D), Vinnova in Sweden (Vinnvinn and Industriforskning programmes), CDTI in Spain (PID Neotec up to €250,000 in non-repayable subsidy), Innosuisse in Switzerland for consortia with Swiss partner. For biotechs, the IMI programme (Innovative Medicines Initiative) co-finances public-private consortia up to €100M. The BoostPro IA simulator cross-references national and European schemes based on your R&D profile and maturity stage.